Spironolactone
Product Images NDC 70934-787

4 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 70934-787). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (70934 787 90 Master Bottle Label Approval Rev A 07 20)

Label (70934 787 90 Master Bottle Label Approval Rev A 07 20)
Spironolactone Tablets USP 100 mg, label showing 90 tablets in the package. The label includes storage instructions, dosage note to see package insert, and states Rx Only. It is packaged by Northwind Pharmaceuticals and directs to keep out of children's reach, store at controlled room temperature, and protect from light.*
FDA Label Image

Figure 1 (Spironolactone Figure 1)

Figure 1 (Spironolactone Figure 1)
A Kaplan-Meier survival curve chart comparing the probability of an event over time in months between Spironolactone and placebo groups. The chart includes sample sizes of 822 for Spironolactone and 841 for placebo, showing a statistically significant difference with a log-rank p-value of less than 0.001.*
FDA Label Image

Figure 2 (Spironolactone Figure 2)

Figure 2 (Spironolactone Figure 2)
A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a study comparing Spironolactone versus placebo. Subgroups include age ranges, sex, race, LVEF percentage, heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, and medication use such as Digoxin, ACE inhibitors, and Beta Blockers. The plot visually compares Spironolactone better to placebo better across these categories.*
FDA Label Image

Chemical Structure (Spironolactone Structure Image)

Chemical Structure (Spironolactone Structure Image)
Chemical structure diagram of the active ingredient spironolactone showing its molecular framework with labeled functional groups including ketones and thioester.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.